Andrew Miller

This inventor holds 32 USPTO granted patents, primarily in Metalloproteinase Inhibitors. Top assignees: British Biotech Pharmaceuticals Limited, British Bio-Technology Limited. Active years: 1993-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Miller. Retrieved from https://idiyas.com/inventor/andrew-miller-qcyckeuq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32

% Patents Active = 96.9

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 188(Granted Patents)

Location History:

Headington, GB (1993)
Oxfordshire, GB (1993 - 1994)
Cowley, GB (1998 - 2000)
Oxford, GB (1993 - 2002)

Company Filing History:

26 out of 85

British Biotech Pharmaceuticals Limited

patents

6 out of 25

British Bio-Technology Limited

patents

Years Active: 1993-2002

Loading Chart...

Areas of Expertise:

Metalloproteinase Inhibitors

PAF Antagonists

Hydroxamic Acid Derivatives

Imidazopyridine Derivatives

Succinamide Derivatives

Cyclic Ether Acetals

Biphenyl Ether

Heterocyclic Sulfonamides

Amino Acid Derivatives

Dual Histamine Antagonists

Matrix Metalloproteinases

Sulfonamide Heterobicyclics

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6358987 - Metalloproteinase inhibitors (2002-03-19),

2. 6271262 - Metalloproteinase inhibitors (2001-08-07),

3. 6124333 - Metalloproteinase inhibitors (2000-09-26),

4. 6124332 - Metalloproteinase inhibitors (2000-09-26),

5. 6124329 - Metalloproteinase inhibitors (2000-09-26),

6. 6103739 - Metalloproteinase inhibitors (2000-08-15),

7. 6028110 - Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and (2000-02-22),

8. 6022898 - Metalloproteinase inhibitors (2000-02-08),

9. 6022873 - Metalloproteinase inhibitors (2000-02-08),

10. 6017889 - Metalloproteinase inhibitors (2000-01-25),

11. 5962529 - Metalloproteinase inhibitors (1999-10-05),

12. 5917090 - Matrix metalloproteinase inhibitors (1999-06-29),

13. 5908851 - Derivatives of succinamide and their use as metalloproteinase inhibitor (1999-06-01),

14. 5902791 - Metalloproteinase inhibitors (1999-05-11),

15. 5866717 - Metalloproteinase inhibitors (1999-02-02),

Title: Andrew Miller - Innovative Inventor from Oxford, GB

Introduction: Andrew Miller is a renowned inventor based in Oxford, GB, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Andrew Miller holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Andrew Miller has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Andrew Miller has collaborated with top companies, patent attorneys, and fellow inventors to bring his ideas to life and secure valuable patents for his innovative creations.

Conclusion: Andrew Miller's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions, with a lasting impact on the future of science and technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]